These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8333226)

  • 1. [Undesirable side effects in thrombolytic therapy].
    Claus G; Gulba DC
    Z Gesamte Inn Med; 1993; 48(6-7):296-303. PubMed ID: 8333226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of laboratory diagnosis in thrombolytic therapy].
    Ostermann H; Kienast J
    Internist (Berl); 1992 Apr; 33(4):252-7. PubMed ID: 1612849
    [No Abstract]   [Full Text] [Related]  

  • 4. New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
    Maksimenko AV; Tischenko EG
    J Thromb Thrombolysis; 1999 Jun; 7(3):307-12. PubMed ID: 10373713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy for venous thromboembolism. Complications and contraindications.
    Levine MN
    Clin Chest Med; 1995 Jun; 16(2):321-8. PubMed ID: 7656543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
    Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
    Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
    Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
    [No Abstract]   [Full Text] [Related]  

  • 10. [The new thrombolytic agents].
    Bassand JP
    Ann Cardiol Angeiol (Paris); 1989 Sep; 38(7 Pt 2):487-91. PubMed ID: 2511796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of thrombolytic agents. Implications for therapy of coronary artery thrombosis.
    Marder VJ
    Circulation; 1983 Aug; 68(2 Pt 2):I2-5. PubMed ID: 6683134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current and future use of thrombolytic therapy.
    Sherry S; Gustafson E
    Annu Rev Pharmacol Toxicol; 1985; 25():413-31. PubMed ID: 3890708
    [No Abstract]   [Full Text] [Related]  

  • 15. The hematologic consequences of thrombolytic therapy.
    Fletcher AP; Alkjaersig NK
    Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
    [No Abstract]   [Full Text] [Related]  

  • 16. Bleeding complications of thrombolytic treatment.
    Marder VJ
    Am J Hosp Pharm; 1990 Sep; 47(9 Suppl 2):S15-9. PubMed ID: 2206051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis.
    Matosevic B; Knoflach M; Werner P; Pechlaner R; Zangerle A; Ruecker M; Kirchmayr M; Willeit J; Kiechl S
    Neurology; 2013 Mar; 80(13):1216-24. PubMed ID: 23486872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy: overview of results in major vascular occlusions.
    Marder VJ
    Thromb Haemost; 1995 Jul; 74(1):101-5. PubMed ID: 8578440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation in thrombolytic therapy: importance and future perspectives].
    Harenberg J; Heene DL
    Z Gesamte Inn Med; 1993; 48(6-7):283-8. PubMed ID: 8333224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of thrombolysis. The need for coadjuvant antithrombotic therapy].
    García Frade LJ; García Avello A
    Rev Clin Esp; 1993 Jun; 193(2):88-92. PubMed ID: 8341821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.